Bone Biologics - Warrants (13/10/2026) OverviewBone Biologics - Warrants (13/10/2026) EBIT
EBIT (Earnings Before Interest and Taxes) analysis for BBLGW.
Quarterly EBIT
-$805.05K
↑ 22.48% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$2.90M
↑ 33.47% YoY
Trailing 12 months ending Mar 31, 2026